• Gibberellin-Induced Autophagic Degradation of DELLA in Arabi

  2026-05-20

  This study reveals that gibberellin promotes ATG8-dependent autophagic degradation of DELLA proteins, driving seed germination and skotomorphogenesis in Arabidopsis under nutrient deprivation. The findings expand our understanding of phytohormone-regulated autophagy, demonstrating a proteostasis mechanism beyond the canonical proteasome pathway and offering new insight into plant stress adaptation.

• Anlotinib hydrochloride (SKU C8688): Reliable Inhibition for

  2026-05-19

  This article addresses persistent laboratory challenges in angiogenesis and cell proliferation assays, highlighting how Anlotinib hydrochloride (SKU C8688) provides reproducible, high-sensitivity results. Drawing on peer-reviewed data, it guides biomedical researchers in deploying this multi-target tyrosine kinase inhibitor for robust, workflow-compatible inhibition of key signaling pathways.

• Acetylcysteine in Tumor Microenvironment Modeling: Advanced

  2026-05-19

  Explore how Acetylcysteine empowers next-generation 3D tumor–stroma models and oxidative stress pathway research. Discover unique mechanistic insights and practical protocol guidance for innovative experimental designs.

• Ciprofloxacin in Antimicrobial Resistance Research Workflows

  2026-05-18

  Ciprofloxacin, a gold-standard fluoroquinolone antibiotic, is indispensable for dissecting DNA replication inhibition and resistance transmission in multidrug-resistant bacteria. This article demystifies advanced workflows, highlights recent breakthroughs from genomic epidemiology, and provides actionable troubleshooting strategies to maximize the impact of APExBIO’s high-purity Ciprofloxacin in laboratory research.

• Dorsomorphin (Compound C): Precision Tools for AMPK and BMP

  2026-05-18

  Dorsomorphin (Compound C) empowers researchers with selective, ATP-competitive inhibition of AMPK and BMP pathways—enabling nuanced dissection of metabolic, autophagic, and differentiation processes. This guide delivers practical protocol enhancements and troubleshooting strategies to maximize reproducibility and data clarity in cellular and animal models.

• Dibutyryl-cAMP, Sodium Salt: Precision in cAMP Pathway Resea

  2026-05-17

  Dibutyryl-cAMP, sodium salt empowers researchers with reliable, cell-permeable activation of cAMP signaling, streamlining workflows in neurodegenerative and inflammation models. Learn how to optimize experimental protocols, troubleshoot challenges, and leverage the latest reference discoveries for deeper insights.

• CLK2-Mediated BRCA1 Phosphorylation Drives Platinum Resistan

  2026-05-16

  This study identifies Cdc2-like kinase 2 (CLK2) as a critical mediator of platinum resistance in ovarian cancer through phosphorylation of BRCA1 at Ser1423, enhancing DNA damage repair. The findings suggest CLK2 as a potential therapeutic target to overcome chemoresistance and provide mechanistic insight into DNA repair pathways relevant for cancer research.

• A23187, Free Acid: Precision Calcium Ionophore for Intracell

  2026-05-15

  A23187, free acid is a well-characterized calcium ionophore used to elevate intracellular Ca2+ and dissect calcium-dependent signaling. Its reproducible induction of phosphoinositide hydrolysis, reactive oxygen species generation, and apoptosis via mitochondrial pathways makes it a benchmark tool in cell biology. APExBIO’s B6646 formulation is widely adopted for reliable mechanistic studies.

• Synthetic Cleavage-Resistant TREM2 Enhances Macrophage Effer

  2026-05-15

  Dong et al. engineered a synthetic, cleavage-resistant TREM2 (CRT) receptor that resists ADAM17-mediated shedding, thereby restoring and amplifying macrophage efferocytosis under inflammatory conditions. Macrophage-selective mRNA delivery of CRT reduced apoptotic cell burden and attenuated inflammation in mouse models of metabolic-dysfunction-associated steatohepatitis and atherosclerosis, highlighting a promising therapeutic strategy for chronic inflammatory diseases.

• Liproxstatin-1: Strategic Insights for Ferroptosis Translati

  2026-05-14

  This thought-leadership article provides a mechanistically informed and strategically actionable framework for translational researchers investigating ferroptosis. By integrating cutting-edge findings on regulated cell death, including recent advances in cuproptosis, and leveraging the unique properties of Liproxstatin-1 as a potent ferroptosis inhibitor, the article delivers a roadmap for experimental rigor, translational relevance, and competitive positioning. Drawing from both published literature and advanced product intelligence, it highlights Liproxstatin-1’s nanomolar potency, specificity, and best-practice deployment in GPX4-deficient and renal injury models, while also reflecting on the evolving competitive and mechanistic landscape. The discussion extends beyond conventional product pages, offering guidance on protocol optimization, cross-domain relevance, and future research priorities.

• Dual Luciferase Reporter Gene System: Precision in Gene Expr

  2026-05-14

  Unlock high-throughput, dual-reporter gene regulation studies with the APExBIO Dual Luciferase Assay System. This platform streamlines workflow, maximizes sensitivity, and enables robust normalization for dissecting complex signaling networks such as the Wnt/β-Catenin axis in cancer research.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-05-13

  Explore how HyperScript™ Reverse Transcriptase enables robust cDNA synthesis for qPCR from challenging RNA templates. This article uniquely connects enzyme mechanisms with advanced transcriptomic applications, including insights from recent retina-gut axis research.

• Therapeutic Targeting of BCL-XL and MCL-1 in Glioblastoma

  2026-05-13

  Koessinger et al. demonstrate that glioblastoma's elevated anti-apoptotic BCL-XL and MCL-1 expression confers heightened sensitivity to BH3-mimetic inhibitors. Their findings highlight a promising vulnerability that may inform future apoptosis-based therapies for resistant brain tumors.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via Ca2+/PI3

  2026-05-12

  Li et al. (2025) uncover a mechanistic role for P2RX1 in promoting mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), identifying calcium/CaMKII-mediated inhibition of PI3K/Akt signaling as a pivotal pathway. Their findings provide new insight into therapeutic vulnerabilities in TKI-resistant Ph+ ALL and underscore the need for robust apoptosis detection methodologies.

• HDAC Inhibitors Repress NUT Carcinoma Oncogenic Programs

  2026-05-12

  Shiota et al. conducted a high-throughput chemical screen revealing diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT carcinoma oncogenic activity. Their findings illuminate the mechanistic basis of HDAC inhibition in disrupting BRD4-NUT-driven transcriptional programs, offering promising therapeutic directions for this aggressive malignancy.

556 records 18/38 page Previous Next First page 上5页 1617181920 下5页 Last page